2-oxo-1H,2H,3H-pyrrolo[3,2-b]pyridine-3-carbonitrile, 97%, 250mg

2-((1R,4R)-4-(4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl)cyclohexyl)acetic acid, 95.0%, 50mg

3',4'-Dimethoxy-2,2,2-trifluoroacetophenone, 97.0%, 1g

2-Bromo-N-methylacetamide, 95.0%, 100g

2-[3,5-Bis(trifluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)5g

Tiocianato di guanidina, 5 kg

4-Chloro-3-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)oxy)aniline, 95.0%, 250mg

[(4-methylphenyl)(4-pyridinyl)methyl]amine dihydrochloride, 95.0%, 10g

2-[(6-chloro-4-ethyl-2-oxo-2H-chromen-7-yl)oxy]propanoic acid, 95.0%, 1g

3 mm NMR Economy Sample Tube w/o Cap, 4" L, High-Throughput, 100x1ea

alpha,alpha,alpha',alpha'-Tetramethyl-1,4-benzenedimethanol, 97.0%, 1g

2-Bromo-4-methoxy-1-nitrobenzene, 95.0%, 10g

2,6-Dihydroxybenzaldehyde, 95.0%, 5g